Evaluating intermittent schedules of the oral RAF-MEK inhibitor CH5126766 in patients with RAS/RAF-mutated solid tumours and multiple myeloma: a single-centre, phase 1 trial.
Year: 2020
Type: article
Authors: Emma Hall, Udai Banerji
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W3080748638
